NINE MASTS CAPITAL Ltd

Position in INBX — Inhibrx Biosciences, Inc.

CIK 1569356 CENTRAL, K3

Position in INBX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$284,250

New position

Shares Held

3,000

first reported quarter

Ownership

0.020%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#109

of 159 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NINE MASTS CAPITAL Ltd holds $2,069,717 across 4 Biotechnology names. INBX ranks #3 (13.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	9,400	$1,247,662
2	VERA	Vera Therapeutics, Inc.	9,434	$404,812
3	INBX	Inhibrx Biosciences, Inc. This page	3,000	$284,250
4	ABVX	Abivax S.A.	998	$132,993

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$284,250	3,000	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.